Mysler, Eduardo
Burmester, Gerd R.
Saffore, Christopher D.
Liu, John
Wegrzyn, Lani
Yang, Chelsey
Betts, Keith A.
Wang, Yan
Irvine, Alan D.
Panaccione, Remo
Funding for this research was provided by:
AbbVie
Article History
Received: 27 August 2023
Accepted: 7 November 2023
First Online: 2 January 2024
Declarations
:
: Christopher Saffore, John Liu, and Lani Wegrzyn are employees of AbbVie, Inc. Chelsey Yang, Keith A. Betts, and Yan Wang are employees of Analysis Group, Inc., which received research funding from AbbVie, Inc. Eduardo Mysler received grants and consulting fees from AbbVie, Amgen, AstraZeneca, Novartis, Lilly, Pfizer, Roche, BMS, Sandoz, GSK, Janssen, Sanofi, Hi Bio Inc., Gemmene and Gema Biotech. Gerd R. Burmester received honoraria for lectures and consulting fees from AbbVie, Amgen, BMS, Lilly, Galapagos, Janssen, Novartis, Pfizer, Sanofi, Roche, Celltrion, Chugai and MSD. Alan D. Irvine received grants or consulting fees or advisory board honoraria from AbbVie, Almirall, Arena, Benevolent AI, Connect Biopharma, Lilly, Janssen, LEO Pharma, Novartis, Pfizer, RAPT Therapeutics, Regeneron, UCB, Sanofi. He is on the board of directors of the International Eczema Council. Remo Panaccione received consulting fees from Abbott, AbbVie, Abbivax, Alimentiv (formerly Robarts), Amgen, Arena Pharmaceuticals, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Cosmos Pharmaceuticals, Eisai, Elan, Eli Lilly, Ferring, Galapagos, Fresenius Kabi, Genentech, Gilead Sciences, GlaxoSmithKline, JAMP Bio, Janssen, Merck, Mylan, Novartis, Oppilan Pharma, Organon, Pandion Pharma, Pendopharm, Pfizer, Progenity, Prometheus Biosciences, Protagonist Therapeutics, Roche, Sandoz, Satisfai Health, Shire, Sublimity Therapeutics, Takeda Pharmaceuticals, Theravance Biopharma, Trellus, Viatris, Ventyx, UCB; has received speaker’s fees from AbbVie, Amgen, Arena Pharmaceuticals, Bristol-Myers Squibb, Celgene, Eli Lilly, Ferring, Fresenius Kabi, Gilead Sciences, Janssen, Merck, Organon, Pfizer, Roche, Sandoz, Shire, Takeda Pharmaceuticals; and has served on advisory boards for AbbVie, Alimentiv (formerly Robarts), Amgen, Arena Pharmaceuticals, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Ferring, Fresenius Kabi, Genentech, Gilead Sciences, GlaxoSmithKline, JAMP Bio, Janssen, Merck, Mylan, Novartis, Oppilan Pharma, Organon, Pandion Pharma, Pfizer, Progenity, Protagonist Therapeutics, Roche, SandozShire, Sublimity Therapeutics, Takeda Pharmaceuticals, Ventyx.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.